GWW
64
6
VLO
40
5
SPG
66
2
WY
37
-2
ICE
69
3
ROP
71
6
CMA
56
4
XRAY
19
3
NWS
88
7
STI
20
-23
BDX
61
2
UNM
68
-3
NDAQ
52
7
HD
38
3
IRM
76
5
YUM
62
4
PLD
48
-8
FMC
34
-5
GPC
43
-2
NUE
44
3
GWW
64
6
VLO
40
5
SPG
66
2
WY
37
-2
ICE
69
3
ROP
71
6
CMA
56
4
XRAY
19
3
NWS
88
7
STI
20
-23
BDX
61
2
UNM
68
-3
NDAQ
52
7
HD
38
3
IRM
76
5
YUM
62
4
PLD
48
-8
FMC
34
-5
GPC
43
-2
NUE
44
3
Financhill
Back

Blueprint Medicines Stock Predictions

Buy
62

BPMC
Blueprint Medicines

Last Price:
106.67
Seasonality Move:
13.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 43.6% based on the past 9 years of stock performance.
  • Blueprint Medicines has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $106.79. The Score for BPMC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 43.6% based on the past 9 years of stock performance.

Blueprint Medicines Stock Rating

Buy
62
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • The current trend is moderately bullish and BPMC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
111.02
52-Week Low:
43.89

Prediction Charts

Market Cap:
6.69B
Price in USD:
106.79
Volume:
758.09K
Beta:
0.87

Technical Analysis

SMA50:
93.88
SMA100:
89.37
SMA200:
73.26
52-Wk Change:
93.67%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 106.79 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-26 92.76 93.00 94.98 90.47
Apr-29 93.52 93.10 94.91 91.12
Apr-30 91.45 91.39 93.37 90.75
May-1 91.44 94.86 96.41 90.85
May-2 103.88 107.00 110.16 100.91
May-3 109.82 107.19 110.93 106.07
May-6 107.93 106.25 108.51 105.48
May-7 105.99 108.67 109.41 103.31
May-8 107.50 108.78 109.15 106.48
May-9 109.00 108.49 109.87 108.00
May-10 108.71 106.70 109.02 106.01
May-13 109.16 108.05 109.48 106.01
May-14 109.53 105.46 111.02 105.27
May-15 107.88 106.79 108.75 106.09

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.